This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,430.89, is for the supply of REXULTI 2 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2023 and was awarded on November 21, 2023. The contract is not designated as a set-aside. AmerisourceBergen...
This is a $3,922.63 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract has a period of performance through February 13, 2025 and is not designated as a set-aside. AmerisourceBergen is the prime contractor and holds a...
This is a $15,157.99 firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of REXULTI 2 MG TABLET 30S, a prescription medication. This delivery order is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,600.04, is for the supply of REXULTI 0.5 MG TABLET 30S, a medication used in the treatment of mental health conditions. The contract has an ultimate completion date of January 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,853.61 firm fixed-price delivery order is for the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 21, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of REXULTI 4 MG TABLET 30S, a pharmaceutical product, with a potential value of $5,308.08 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation mentioned. The contract is part of a larger indefinite delivery...
This is a $15,363.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of REXULTI 2 MG TABLET 30S, which is a prescription medication. The contract has an ultimate completion date of August 9, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,077.50, is for the delivery of REXULTI 2 MG TABLET 30S, a prescription medication. The contract has a completion date of January 15, 2025 and uses a firm fixed price pricing type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REXULTI 0.5 MG TABLET 30S, a prescription medication. The award has a firm fixed price, a ceiling value of $6,103.11, and an ultimate completion date of June 5, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $1,951.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, with a completion date of January 3, 2025. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...